Candriam SCA’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-66,329
| Closed | -$340K | – | 891 |
|
|
2021
Q3 | $340K | Hold |
66,329
| – | – | ﹤0.01% | 801 |
|
|
2021
Q2 | $551K | Sell |
66,329
-39,561
| -37% | -$329K | ﹤0.01% | 790 |
|
|
2021
Q1 | $1.11M | Hold |
105,890
| – | – | 0.01% | 618 |
|
|
2020
Q4 | $1.15M | Sell |
105,890
-255,262
| -71% | -$2.77M | 0.01% | 630 |
|
|
2020
Q3 | $4.31M | Buy |
361,152
+96,138
| +36% | +$1.15M | 0.04% | 373 |
|
|
2020
Q2 | $4.26M | Buy |
265,014
+47,638
| +22% | +$765K | 0.04% | 365 |
|
|
2020
Q1 | $5.23M | Buy |
217,376
+38
| +0% | +$914 | 0.06% | 334 |
|
|
2019
Q4 | $5.35M | Buy |
217,338
+105,838
| +95% | +$2.6M | 0.06% | 341 |
|
|
2019
Q3 | $1.15M | Buy |
+111,500
| New | +$1.15M | 0.02% | 585 |
|
|
2017
Q2 | – | Sell |
-192,000
| Closed | -$3.29M | – | 723 |
|
|
2017
Q1 | $3.29M | Sell |
192,000
-17,000
| -8% | -$292K | 0.06% | 349 |
|
|
2016
Q4 | $2.53M | Buy |
209,000
+25,000
| +14% | +$303K | 0.06% | 323 |
|
|
2016
Q3 | $1.81M | Hold |
184,000
| – | – | 0.04% | 375 |
|
|
2016
Q2 | $1.88M | Buy |
184,000
+24,000
| +15% | +$246K | 0.05% | 324 |
|
|
2016
Q1 | $1.93M | Sell |
160,000
-21,000
| -12% | -$253K | 0.05% | 329 |
|
|
2015
Q4 | $2.9M | Buy |
181,000
+25,000
| +16% | +$401K | 0.08% | 254 |
|
|
2015
Q3 | $2.01M | Sell |
156,000
-6,000
| -4% | -$77.2K | 0.05% | 341 |
|
|
2015
Q2 | $3.89M | Buy |
162,000
+32,000
| +25% | +$768K | 0.08% | 276 |
|
|
2015
Q1 | $2.44M | Buy |
130,000
+60,000
| +86% | +$1.13M | 0.05% | 361 |
|
|
2014
Q4 | $1.32M | Buy |
+70,000
| New | +$1.32M | 0.03% | 413 |
|